321 related articles for article (PubMed ID: 37294394)
21. Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group.
Sośnia O; Pruszczyk K; Danecki M; Wąsik-Szczepanek E; Tryc-Szponder J; Iskierka-Jażdżewska E; Majeranowski A; Krzemień H; Bołkun Ł; Paszkiewicz-Kozik E; Drozd-Sokołowska J; Kwiatkowski J; Wiśniewska-Organek D; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Budziszewska B; Jamroziak K; Hus I; Lech-Marańda E; Puła B
Leuk Lymphoma; 2024 Feb; 65(2):175-186. PubMed ID: 37921067
[TBL] [Abstract][Full Text] [Related]
22. Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma.
Buckley T; Inamdar A; Mikhail NH; Loo A; Cohen S
Am J Case Rep; 2021 Dec; 22():e932904. PubMed ID: 34934038
[TBL] [Abstract][Full Text] [Related]
23. Emerging Therapies for the Management of Richter Transformation.
Smyth E; Eyre TA; Cheah CY
J Clin Oncol; 2023 Jan; 41(2):395-409. PubMed ID: 36130148
[TBL] [Abstract][Full Text] [Related]
24. How we treat Richter syndrome.
Parikh SA; Kay NE; Shanafelt TD
Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
26. [Richter Syndrome: Diagnostic and Therapeutic Management].
Croizier C; Guièze R
Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
[TBL] [Abstract][Full Text] [Related]
27. PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter Transformation.
Rhodes JM; Mato AR
PET Clin; 2019 Jul; 14(3):405-410. PubMed ID: 31084779
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.
Wang Y; Tschautscher MA; Rabe KG; Call TG; Leis JF; Kenderian SS; Kay NE; Muchtar E; Van Dyke DL; Koehler AB; Schwager SM; Slager SL; Parikh SA; Ding W
Haematologica; 2020 Mar; 105(3):765-773. PubMed ID: 31197071
[TBL] [Abstract][Full Text] [Related]
29. Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.
García-Barchino MJ; Sarasquete ME; Panizo C; Morscio J; Martinez A; Alcoceba M; Fresquet V; Gonzalez-Farre B; Paiva B; Young KH; Robles EF; Roa S; Celay J; Larrayoz M; Rossi D; Gaidano G; Montes-Moreno S; Piris MA; Balanzategui A; Jimenez C; Rodriguez I; Calasanz MJ; Larrayoz MJ; Segura V; Garcia-Muñoz R; Rabasa MP; Yi S; Li J; Zhang M; Xu-Monette ZY; Puig-Moron N; Orfao A; Böttcher S; Hernandez-Rivas JM; Miguel JS; Prosper F; Tousseyn T; Sagaert X; Gonzalez M; Martinez-Climent JA
J Pathol; 2018 May; 245(1):61-73. PubMed ID: 29464716
[TBL] [Abstract][Full Text] [Related]
30. Richter Transformation Arising From Chronic Lymphocytic Leukemia.
Barnes Rogers B
Clin J Oncol Nurs; 2022 Feb; 26(1):14-17. PubMed ID: 35073287
[TBL] [Abstract][Full Text] [Related]
31. Artificial intelligence strategy integrating morphologic and architectural biomarkers provides robust diagnostic accuracy for disease progression in chronic lymphocytic leukemia.
El Hussein S; Chen P; Medeiros LJ; Wistuba II; Jaffray D; Wu J; Khoury JD
J Pathol; 2022 Jan; 256(1):4-14. PubMed ID: 34505705
[TBL] [Abstract][Full Text] [Related]
32. TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression.
Symes E; Wang P; Lager AM; Bishop MR; Aqil B; Venkataraman G
Leuk Lymphoma; 2022 Nov; 63(11):2735-2738. PubMed ID: 35719104
[No Abstract] [Full Text] [Related]
33. [Richter syndrome: clinical characteristics and treatment experiences].
Li ZJ; Xu Y; Zhang PH; Liu W; Yi SH; Zou DH; Qi JY; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3254-6. PubMed ID: 23328508
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for Richter syndrome in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Curr Hematol Malig Rep; 2014 Sep; 9(3):294-9. PubMed ID: 25218362
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Richter's Syndrome.
Condoluci A; Rossi D
Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
Hess B; Kalmuk J; Znoyko I; Schandl CA; Wagner-Johnston N; Mazzoni S; Hendrickson L; Chiad Z; Greenwell IB; Wolff DJ
Cancer Genet; 2022 Jan; 260-261():18-22. PubMed ID: 34808593
[TBL] [Abstract][Full Text] [Related]
37. Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.
Chitalia A; Swoboda DM; McCutcheon JN; Ozdemirli M; Khan N; Cheson BD
Leuk Lymphoma; 2019 Apr; 60(4):971-979. PubMed ID: 30632835
[TBL] [Abstract][Full Text] [Related]
38. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
Iovino L; Shadman M
Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
[TBL] [Abstract][Full Text] [Related]
39. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
Playa-Albinyana H; Arenas F; Royo R; Giró A; López-Oreja I; Aymerich M; López-Guerra M; Frigola G; Beà S; Delgado J; Garcia-Roves PM; Campo E; Nadeu F; Colomer D
Leukemia; 2024 Mar; 38(3):557-569. PubMed ID: 38017105
[TBL] [Abstract][Full Text] [Related]
40. Richter transformation in Chronic Lymphocytic Leukemia.
Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
